THERAPEUTIC AREAS

BLEEDING


Intranasal bleeding (« epistaxis ») affects close to 10% of worldwide population, i.e. 750 million patients (out of which 10% require medical attention).

0

CHRONIC SINUSITIS


Chronic rhinosinusitis impacts approximately 12% of the general population, or by around 900 million patients.

0

50%

Current treatments are ineffective in 30 to 50% of the patients

20%

20% of patients suffering from chronic sinusitis face treatment failure

OUR ANALYSIS

Intranasal bleeding and chronic sinusitis significantly impact patients quality of life. Usage of current treatments may lead to preventable surgical procedures and hospitalizations.

WHY?

current treatments are often ineffective, not well tolerated or invasive

current product features do not allow early hospital discharge and lead to frequent follow-up visits and rehospitalizations

OUR SOLUTIONS

A portfolio of innovative and economically affordable medical devices allowing patients to get back home quicker and return faster to everyday life activities

Rapidly effective

Safe and minimally invasive

Easy to use

Quick return to home

Response to medical desertification

Cost-effective